These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37533208)

  • 1. Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis.
    Zhou R; Yang L; Zhang B; Gu Y; Kong T; Zhang W; Sun L; Liu C; Kong N; Li J; Shi J
    J Viral Hepat; 2023 Oct; 30(10):793-802. PubMed ID: 37533208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.
    Wong YJ; Nguyen VH; Yang HI; Li J; Le MH; Wu WJ; Han NX; Fong KY; Chen E; Wong C; Rui F; Xu X; Xue Q; Hu XY; Leow WQ; Goh GB; Cheung R; Wong G; Wong VW; Yu MW; Nguyen MH
    Clin Mol Hepatol; 2023 Jul; 29(3):705-720. PubMed ID: 37157776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection.
    Poortahmasebi V; Alavian SM; Keyvani H; Norouzi M; Mahmoodi M; Jazayeri SM
    Asian Pac J Cancer Prev; 2014; 15(9):3879-84. PubMed ID: 24935567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B.
    Zheng Q; Zou B; Wu Y; Yeo Y; Wu H; Stave CD; Cheung RC; Nguyen MH
    Aliment Pharmacol Ther; 2021 Nov; 54(9):1100-1109. PubMed ID: 34469587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
    Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
    Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. East Asia expert opinion on treatment initiation for chronic hepatitis B.
    Kao JH; Hu TH; Jia J; Kurosaki M; Lim YS; Lin HC; Sinn DH; Tanaka Y; Wai-Sun Wong V; Yuen MF
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1540-1550. PubMed ID: 32951256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis.
    Jiang D; Chen C; Liu X; Huang C; Yan D; Zhang X; Zhou Y; Lin Y; Zhou Y; Guan Z; Ding C; Lan L; Zhu C; Wu J; Li L; Yang S
    Ann Transl Med; 2021 Dec; 9(23):1718. PubMed ID: 35071412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
    Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
    World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.
    Lee J; Yoo SH; Sohn W; Kim HW; Choi YS; Won JH; Heo JY; Park SJ; Park YM
    Clin Mol Hepatol; 2016 Sep; 22(3):339-349. PubMed ID: 27729627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of non-invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis.
    Lin KW; Kumar R; Shen F; Chan HL; Wong GL; Kumar R; Chow WC; Lin S; Wong VW; Fan JG; Goh GB
    Liver Int; 2023 May; 43(5):1008-1014. PubMed ID: 36855842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B?
    Karacaer Z; Okur G; Cermik H; Altun D
    Postgrad Med; 2016 Sep; 128(7):697-700. PubMed ID: 27499150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.
    Seto WK; Hui RWH; Mak LY; Fung J; Cheung KS; Liu KSH; Wong DK; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):575-583.e2. PubMed ID: 28970146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis.
    Mao X; Cheung KS; Peng C; Mak LY; Cheng HM; Fung J; Peleg N; Leung HH; Kumar R; Lee JH; Shlomai A; Yuen MF; Seto WK
    Hepatology; 2023 May; 77(5):1735-1745. PubMed ID: 36111362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
    Yang M; Wei L
    Liver Int; 2022 Aug; 42(9):1981-1990. PubMed ID: 35373500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
    Lee MH; Chen YT; Huang YH; Lu SN; Yang TH; Huang JF; Yin SC; Yeh ML; Huang CF; Dai CY; Chuang WL; Yu ML; Yang HI; Chen HY; Chen CJ
    Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1275-1285.e2. PubMed ID: 38365094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.
    Jin X; Chen YP; Yang YD; Li YM; Zheng L; Xu CQ
    PLoS One; 2012; 7(3):e34198. PubMed ID: 22479562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.
    Zheng RD; Chen JN; Zhuang QY; Lu YH; Chen J; Chen BF
    Int J Med Sci; 2013; 10(5):641-6. PubMed ID: 23569427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
    Li J; Yang HI; Yeh ML; Le MH; Le AK; Yeo YH; Dai CY; Barnett S; Zhang JQ; Huang JF; Trinh HN; Wong C; Wong C; Hoang JK; Cheung R; Yu ML; Nguyen MH
    J Infect Dis; 2021 Jul; 224(2):294-302. PubMed ID: 33249474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.